These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
748 related articles for article (PubMed ID: 29360497)
1. Metabolomics-based mechanisms exploration of Huang-Lian Jie-Du decoction on cerebral ischemia via UPLC-Q-TOF/MS analysis on rat serum. Zhu B; Cao H; Sun L; Li B; Guo L; Duan J; Zhu H; Zhang Q J Ethnopharmacol; 2018 Apr; 216():147-156. PubMed ID: 29360497 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of Huang-Lian-Jie-Du-Decoction on ischemic stroke rats revealed by (1)H NMR metabolomics approach. Wang PR; Wang JS; Yang MH; Kong LY J Pharm Biomed Anal; 2014 Jan; 88():106-16. PubMed ID: 24051274 [TBL] [Abstract][Full Text] [Related]
3. The components of Huang-Lian-Jie-Du-Decoction act synergistically to exert protective effects in a rat ischemic stroke model. Zhang Q; Wang J; Zhang C; Liao S; Li P; Xu D; Lv Y; Yang M; Kong L Oncotarget; 2016 Dec; 7(49):80872-80887. PubMed ID: 27779107 [TBL] [Abstract][Full Text] [Related]
4. Metabolomics study on the effects of Buchang Naoxintong capsules for treating cerebral ischemia in rats using UPLC-Q/TOF-MS. Liu M; Liu X; Wang H; Xiao H; Jing F; Tang L; Li D; Zhang Y; Wu H; Yang H J Ethnopharmacol; 2016 Mar; 180():1-11. PubMed ID: 26806568 [TBL] [Abstract][Full Text] [Related]
5. Huang-Lian-Jie-Du-Decotion induced protective autophagy against the injury of cerebral ischemia/reperfusion via MAPK-mTOR signaling pathway. Wang PR; Wang JS; Zhang C; Song XF; Tian N; Kong LY J Ethnopharmacol; 2013 Aug; 149(1):270-80. PubMed ID: 23811213 [TBL] [Abstract][Full Text] [Related]
6. Induced cortical neurogenesis after focal cerebral ischemia--Three active components from Huang-Lian-Jie-Du Decoction. Zou H; Long J; Zhang Q; Zhao H; Bian B; Wang Y; Zhang J; Zhao H; Wang L J Ethnopharmacol; 2016 Feb; 178():115-24. PubMed ID: 26657578 [TBL] [Abstract][Full Text] [Related]
7. Explore of the beneficial effects of Huang-Lian-Jie-Du Decoction on diabetic encephalopathy in db/db mice by UPLC-Q-Orbitrap HRMS/MS based untargeted metabolomics analysis. He WJ; Cao DM; Chen YB; Shi JJ; Hu T; Zhang ZT; Lan T; Tang D; Wang SM J Pharm Biomed Anal; 2021 Jan; 192():113652. PubMed ID: 33039912 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of Huang-lian-Jie-du decoction and its effective fraction in alleviating acute ulcerative colitis in mice: Regulating arachidonic acid metabolism and glycerophospholipid metabolism. Yuan Z; Yang L; Zhang X; Ji P; Hua Y; Wei Y J Ethnopharmacol; 2020 Sep; 259():112872. PubMed ID: 32417423 [TBL] [Abstract][Full Text] [Related]
9. Metabolomic analysis of biochemical changes in the plasma and urine of collagen-induced arthritis in rats after treatment with Huang-Lian-Jie-Du-Tang. Zhang H; Fu P; Ke B; Wang S; Li M; Han L; Peng C; Zhang W; Liu R J Ethnopharmacol; 2014 May; 154(1):55-64. PubMed ID: 24709313 [TBL] [Abstract][Full Text] [Related]
10. Metabolic fate analysis of Huang-Lian-Jie-Du Decoction in rat urine and feces by LC-IT-MS combining with LC-FT-ICR-MS: a feasible strategy for the metabolism study of Chinese medical formula. Zuo R; Ren W; Bian BL; Wang HJ; Wang YN; Hu H; Zhao HY; Si N Xenobiotica; 2016; 46(1):65-81. PubMed ID: 26084375 [TBL] [Abstract][Full Text] [Related]
11. Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice. Tang D; He WJ; Zhang ZT; Shi JJ; Wang X; Gu WT; Chen ZQ; Xu YH; Chen YB; Wang SM Phytomedicine; 2022 Jan; 95():153777. PubMed ID: 34815154 [TBL] [Abstract][Full Text] [Related]
12. Deciphering the mechanism of Huang-Lian-Jie-Du-Decoction on the treatment of sepsis by formula decomposition and metabolomics: Enhancement of cholinergic pathways and inhibition of HMGB-1/TLR4/NF-κB signaling. Xu D; Lv Y; Wang J; Yang M; Kong L Pharmacol Res; 2017 Jul; 121():94-113. PubMed ID: 28434923 [TBL] [Abstract][Full Text] [Related]
13. DanHong injection dose-dependently varies amino acid metabolites and metabolic pathways in the treatment of rats with cerebral ischemia. Guo ZL; Zhu Y; Su XT; Liu J; Yang QX; Nan JY; Zhao BC; Zhang YY; Yu YN; Li B; Xiao HB; Wang Z Acta Pharmacol Sin; 2015 Jun; 36(6):748-57. PubMed ID: 25937632 [TBL] [Abstract][Full Text] [Related]
14. Treatment Effects of Ischemic Stroke by Berberine, Baicalin, and Jasminoidin from Huang-Lian-Jie-Du-Decoction (HLJDD) Explored by an Integrated Metabolomics Approach. Zhang Q; Fu X; Wang J; Yang M; Kong L Oxid Med Cell Longev; 2017; 2017():9848594. PubMed ID: 28894512 [TBL] [Abstract][Full Text] [Related]
15. Preconditioning with the traditional Chinese medicine Huang-Lian-Jie-Du-Tang initiates HIF-1α-dependent neuroprotection against cerebral ischemia in rats. Zhang Q; Bian H; Li Y; Guo L; Tang Y; Zhu H J Ethnopharmacol; 2014 Jun; 154(2):443-52. PubMed ID: 24751364 [TBL] [Abstract][Full Text] [Related]
16. Metabolic profiles revealed anti-ischemia-reperfusion injury of Yangxinshi tablet in Rats. Zhang H; Zhao Y; Xia Z; Du H; Gao Y; Xue D; Zhu Z; Chai Y J Ethnopharmacol; 2018 Mar; 214():124-133. PubMed ID: 28889959 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic-Pharmacodynamic Analysis on Inflammation Rat Model after Oral Administration of Huang Lian Jie Du Decoction. Ren W; Zuo R; Wang YN; Wang HJ; Yang J; Xin SK; Han LY; Zhao HY; Han SY; Gao B; Hu H; Hu YJ; Bian BL; Si N PLoS One; 2016; 11(6):e0156256. PubMed ID: 27280291 [TBL] [Abstract][Full Text] [Related]
18. Lipidomics study of plasma phospholipid metabolism in early type 2 diabetes rats with ancient prescription Huang-Qi-San intervention by UPLC/Q-TOF-MS and correlation coefficient. Wu X; Zhu JC; Zhang Y; Li WM; Rong XL; Feng YF Chem Biol Interact; 2016 Aug; 256():71-84. PubMed ID: 27369808 [TBL] [Abstract][Full Text] [Related]
19. Fu X; Wang J; Liao S; Lv Y; Xu D; Yang M; Kong L Front Pharmacol; 2019; 10():337. PubMed ID: 31031621 [TBL] [Abstract][Full Text] [Related]
20. Huang-Lian Jie-Du decoction: a review on phytochemical, pharmacological and pharmacokinetic investigations. Qi Y; Zhang Q; Zhu H Chin Med; 2019; 14():57. PubMed ID: 31867052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]